Therefore, it would be reasonable to assume that the phytocompounds, which have an inhibitory interaction with NOX4, could exert some beneficial effects on both the vascular and fibrotic pathogenic branches of SSc. This evidence concerns the gene NOX4 and systemic sclerosis.